vascular closure devices market outlook, vascular closure devices market scope, vascular closure devices market share, vascular closure devices market growth, vascular closure devices market research, vascular closure devices market segments
How large is the vascular closure devices market, and what is its growth trajectory?
The vascular closure devices market size has grown strongly in recent years. It will grow from $1.53 billion in 2024 to $1.63 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to growth in minimally invasive procedures, aging population demographics, patient preference for shorter recovery times, increased catheterization lab procedures, focus on outpatient care.
The vascular closure devices market size is expected to see strong growth in the next few years. It will grow to $2.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rise in ambulatory surgery centers, shift toward same-day discharge, patient-centric approaches, healthcare cost containment initiatives, increasing incidence of cardiovascular diseases. Major trends in the forecast period include adoption of percutaneous coronary intervention, global collaboration in medical research, remote patient monitoring, integration with imaging technologies, technological innovations in device design.
Get Your Free Sample of The Global Vascular Closure Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13201&type=smp
What are the key forces behind the vascular closure devices market’s growth in recent years?
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the vascular closure devices market. Cardiovascular disease (CVD) refers to conditions that affect the structures or function of the heart or blood vessels, affecting blood flow to the heart. Vascular closure devices (VCDs) are a substitute for conventional mechanical compression to close the femoral artery and offer rapid sealing of the femoral artery access site, potentially resulting in quicker attainment of hemostasis and a reduced risk of bleeding or hemorrhage following placement. For instance, in June 2023, according to the Immigration and Checkpoints Authority, a Singapore-based law enforcement agency, the number of people who died from heart and hypertensive diseases in Singapore increased from 6,238 in 2021 to 6,884 in 2022. Therefore, the increasing prevalence of cardiovascular diseases is expected to propel the growth of the vascular closure devices market.
What are the major segments of the vascular closure devices market?
The vascular closure devices market covered in this report is segmented –
1) By Type: Passive Approximators, Active Approximators, External Hemostatic Devices
2) By Access: Femoral Access, Radial Access
3) By End User: Acute Care Facilities, Hospitals, Clinics, Other End Users
Subsegments:
1) By Passive Approximators: Suture-Based Devices, Fibrin Sealants
2) By Active Approximators: Mechanical Devices, Expanding Devices
3) By External Hemostatic Devices: Compression Bandages, Adjustable Hemostatic Devices
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/vascular-closure-devices-global-market-report
Which companies dominate the vascular closure devices market?
Major companies operating in the vascular closure devices market report are Cardinal Health Inc., Abbott Laboratories, Medtronic PLC, Koninklijke Philips NV, Boston Scientific Corporation, Terumo Corporation, C.R. Bard Inc., Cook Medical Inc., W. L. Gore & Associates Inc., Maquet Getinge Group, Teleflex Inc., BTG International Inc., Biotronik GMBH & CO.KG, Merit Medical System Inc., Vygon SA, Cardiovascular Systems Inc., Sirtex Medical Limited, Endologix LLC, TZ Medical Inc., Cardiva Medical Inc., Essential Medical Inc., KOAG LLC, Morris Innovative Inc., Vasorum Ltd., Scion BioMedical Inc., Z-Media LLC, Advanced Vascular Dynamics, Transluminal Technologies Inc., Tricol Medical Inc.
What major trends will shape the vascular closure devices market during the forecast period?
Major companies operating in the vascular closure devices market are focused on developing technologies such as innovative collapsible disc technology to enhance patient outcomes, reduce recovery times, and improve the overall effectiveness and ease of vascular procedures. Innovative collapsible disc technology involves a design that allows a disc to be easily collapsed and expanded for efficient storage and portability. This technology enhances convenience and versatility in various applications, such as sporting goods, outdoor gear, or packaging solutions. For instance, in June 2024, Haemonetics Corporation, a US-based medical technology company, launched VASCADE MVP XL. VASCADE MVP XL is a mid-bore vascular closure device. The VASCADE MVP XL incorporates 58% more collagen and a larger disc compared to its predecessor, the VASCADE MVP system. This design aims to provide a more robust closure solution, facilitating quicker recovery and improved patient outcomes.
What are the key regional dynamics of the vascular closure devices market, and which region leads in market share?
North America was the largest region in the vascular closure devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular closure devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Does The Vascular Closure Devices Market Report 2025 Offer?
The vascular closure devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
A vascular closure device is a medical device that seals the entry point in an artery after a catheterization procedure. These devices are designed to accelerate the natural healing process and minimize the risk of bleeding, hematoma formation, or other complications at the access site.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13201
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
